152 related articles for article (PubMed ID: 2389716)
1. New insights into the management of myocardial ischemia. Overview.
Abrams J
Am Heart J; 1990 Sep; 120(3):719-21; discussion 743-5. PubMed ID: 2389716
[TBL] [Abstract][Full Text] [Related]
2. [Characteristics of angina pectoris therapy with nitrates].
Silber S
Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
[TBL] [Abstract][Full Text] [Related]
3. Oral nitrates: more than symptomatic therapy in coronary artery disease?
Thadani U
Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():213-8. PubMed ID: 9211013
[TBL] [Abstract][Full Text] [Related]
4. [Organic nitrates. I. Mechanism of action and new therapeutic approaches in myocardial ischemia].
Schrör K
Internist (Berl); 1995 Apr; 36(4):392-7. PubMed ID: 7775091
[No Abstract] [Full Text] [Related]
5. A reappraisal of nitrate therapy.
Abrams J
JAMA; 1988 Jan; 259(3):396-401. PubMed ID: 3275814
[TBL] [Abstract][Full Text] [Related]
6. Beneficial actions of nitrates in cardiovascular disease.
Abrams J
Am J Cardiol; 1996 May; 77(13):31C-7C. PubMed ID: 8638524
[TBL] [Abstract][Full Text] [Related]
7. Role of nitrates for the therapy of coronary artery disease patients in the years beyond 2000.
Darius H
J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 2():S15-20; discussion S29-31. PubMed ID: 10499556
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic vasodilators in the coronary circulation.
Schwartz JS; Bache RJ
Circulation; 1987 Jan; 75(1 Pt 2):I162-7. PubMed ID: 3791617
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia.
Abrams J
Am J Cardiol; 1992 Sep; 70(8):30B-42B. PubMed ID: 1529924
[TBL] [Abstract][Full Text] [Related]
10. Nitrate therapy for ischaemic heart disease.
Conti CR
Eur Heart J; 1985 Jan; 6 Suppl A():3-11. PubMed ID: 3996435
[TBL] [Abstract][Full Text] [Related]
11. Use of nitrates in ischemic heart disease.
Abrams J
Curr Probl Cardiol; 1992 Aug; 17(8):481-542. PubMed ID: 1511614
[TBL] [Abstract][Full Text] [Related]
12. Nitrate therapy for myocardial ischemic syndrome: current perspectives including tolerance.
Thadani U; Whitsett T; Hamilton SF
Curr Probl Cardiol; 1988 Nov; 13(11):723-84. PubMed ID: 3069336
[No Abstract] [Full Text] [Related]
13. Coronary spasm, steal, and stenosis: implications for management of ischemic heart disease.
Kern MJ; Miller JT
Curr Probl Cardiol; 1986 Jan; 11(1):1-67. PubMed ID: 2867859
[No Abstract] [Full Text] [Related]
14. [Clinical trial of the new coronary dilator hexobendine].
Henke C; Dudik E; Steim H
Arzneimittelforschung; 1968 Aug; 18(8):1103-7. PubMed ID: 4885101
[No Abstract] [Full Text] [Related]
15. [Recent progress regarding nitrates and their use in stable and unstable angina pectoris, pre-infarction syndrome and myocardial infarct].
Lichtlen PR
Internist (Berl); 1992 Oct; 33(10):684-94. PubMed ID: 1428686
[No Abstract] [Full Text] [Related]
16. [Drugs for the management of chronic ischemic heart disease].
Klotzbach M
Pharmazie; 1979 Aug; 34(8):487-90. PubMed ID: 43982
[No Abstract] [Full Text] [Related]
17. Medical management of stable angina and unstable angina in the elderly with coronary artery disease.
Olson HG; Aronow WS
Clin Geriatr Med; 1996 Feb; 12(1):121-40. PubMed ID: 8653654
[TBL] [Abstract][Full Text] [Related]
18. [Medical aspects of the treatment of acute coronary disease].
Amann FW; Ritz R
Schweiz Med Wochenschr Suppl; 1984; 16():30-3. PubMed ID: 6588547
[TBL] [Abstract][Full Text] [Related]
19. Nitroglycerin and long-acting nitrates.
Abrams J
N Engl J Med; 1980 May; 302(22):1234-7. PubMed ID: 6767984
[No Abstract] [Full Text] [Related]
20. [Cardioprotection with drugs. 1: Coronary heart disease].
Michel D
Fortschr Med; 1990 Jan; 108(3):40-4. PubMed ID: 1968878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
